Total Research Group has built a strong reputation for conducting safe, ethical, and high-quality clinical trials. Over the years, our experienced team has successfully completed numerous studies, consistently delivering accurate data, reliable results, and patient-centered care. This proven track record highlights Total Research Group’s competitive edge, our commitment to scientific rigor, regulatory compliance, and patient safety.
Past Studies
Past Clinical Trials


Chronic Kidney Disease
The participation and trust of those who took part in these studies have been instrumental in advancing promising research into chronic kidney disease, offering hope to patients and helping shape the potential for more effective, longer-term care.
Current Status
Not Recruiting

Anemia in CKD - Correction / Dialysis-dependent Chronic Kidney Disease
Because of the dedication of our participants, these studies have contributed to exploring promising treatment approaches for anemia in chronic kidney disease, offering hope to those managing the compounding challenges of dialysis-dependent CKD.
Current Status
Not Recruiting

Anemia in CKD - Maintenance / Dialysis-Dependent Chronic Kidney Disease
The generosity of our participants made these studies possible, helping advance the potential for better long-term anemia management in dialysis-dependent CKD and offering hope for more consistent, effective care over time.
Current Status
Not Recruiting

ESRD / Hyperphosphatemia
Every participant who took part in these studies helped move promising research forward, contributing to the potential for better phosphate control in end-stage renal disease and helping shape the future of ESRD care.
Current Status
Not Recruiting

Anemia in ESRD / Dialysis-Dependent Chronic Kidney Disease
The courage and commitment of our participants drove these studies forward, contributing to the development of promising anemia therapies for those navigating the unique challenges of end-stage renal disease and life on dialysis.
Current Status
Not Recruiting

Hyperphosphatemia in ESRD / Hyperphosphatemia
Rooted in the trust our participants placed in this research, these studies have advanced promising approaches to hyperphosphatemia management in ESRD, offering hope to patients at risk of serious cardiovascular and bone health complications.
Current Status
Not Recruiting

Focal Segmental Glomerulosclerosis
With sincere appreciation, we extend our gratitude to every participant who contributed to this study. Your willingness to take part, along with your time and trust, has supported important efforts to evaluate the long-term kidney-protective potential of an investigational drug compared with an angiotensin receptor blocker in patients with primary and genetic focal segmental glomerulosclerosis (FSGS). Your involvement has helped deepen understanding of this condition and contributed to improving future care and treatment options for individuals affected by FSGS.
Current Status
Not Recruiting

Hyperphosphatemia
With sincere appreciation, we extend our gratitude to every participant who contributed to this study. Your willingness to take part, along with your time and trust, has supported important efforts to evaluate the ability of an investigational drug alone or in combination with a standard drug to achieve serum phosphorus levels in patients with end-stage renal disease (ESRD) on dialysis with hyperphosphatemia. Your involvement has helped expand knowledge of this condition and contributed to advancing care options for patients with ESRD and elevated phosphorus levels.
Current Status
Not Recruiting

Anemia in CKD
With sincere appreciation, we extend our gratitude to every participant who contributed to this study. Your willingness to take part, along with your time and trust, has supported important efforts to evaluate the safety and efficacy of an investigational drug for the treatment of anemia in patients with chronic kidney disease not on dialysis. Your involvement has helped deepen understanding of this condition and contributed to improving future treatment options for people living with anemia associated with chronic kidney disease.
Current Status
Not Recruiting

Cardio-Renal Outcomes
Thanks to the commitment of our participants and research teams, this research study has contributed to advancing the understanding of chronic kidney disease and potential ways to slow its progression. This clinical research has helped strengthen evidence around improving kidney and heart health outcomes in people living with CKD, bringing hope for better future care and treatment options.
Current Status
Not Recruiting

Uncontrolled Gout
Because of the dedication of our participants and the efforts of the research teams, this study has added valuable insights into the management of uncontrolled gout in kidney transplant patients. It has helped build a stronger understanding of treatment response and safety in this complex group, supporting ongoing research and future possibilities for improved care in post-transplant gout management.
Current Status
Not Recruiting

Non-Dialysis-Dependent Chronic Kidney Disease
With the dedication of participants and research teams, this study has contributed to a better understanding of anemia in chronic kidney disease. It has strengthened evidence around hemoglobin improvement in non-dialysis CKD, helping pave the way for future research and treatment development.
Current Status
Not Recruiting

Anemia / Non-Dialysis-Dependent Chronic Kidney Disease
We sincerely thank all participants, caregivers, and healthcare professionals who took part in this completed study. Your contribution helped advance research for people living with non-dialysis-dependent chronic kidney disease (NDD-CKD). This Phase 3 study aimed to evaluate how well an investigational treatment could maintain healthy hemoglobin levels and manage anemia compared with an active treatment option.
Current Status
Not Recruiting

Anemia of Chronic Kidney Disease
We sincerely thank all participants who took part in this clinical study. Your time, trust, and commitment played an important role in advancing research for people living with chronic kidney disease and anemia. Through your participation, valuable insights were gained to help evaluate potential new treatment approaches and support future progress in patient care.
Current Status
Not Recruiting

CKD and Uncontrolled Hypertension
We sincerely thank everyone who took part in this clinical study. Your time, commitment, and willingness to participate helped advance research for adults living with chronic kidney disease and uncontrolled high blood pressure. Contributions like yours play an important role in improving future treatment options and bringing hope to patients worldwide.
Current Status
Not Recruiting






